Hubert H. Fernandez, M.D.

Affiliations: 
McKnight Brain Institute University of Florida College of Medicine/McKnight Brain Institute, Gainesville 
Google:
"Hubert Fernandez"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Koh EJ, Golubovsky JL, Rammo R, et al. (2021) Estimating the Risk of Deep Brain Stimulation in the Modern Era: 2008 to 2020. Operative Neurosurgery (Hagerstown, Md.)
Fox SH, Swan M, Jinnah HA, et al. (2021) An Open-Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia. Movement Disorders Clinical Practice. 8: 743-749
Bluett B, Pantelyat AY, Litvan I, et al. (2021) Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care. Frontiers in Neurology. 12: 694872
Hauser RA, Barkay H, Fernandez HH, et al. (2021) Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study. Cns Spectrums. 26: 162
Jimenez-Shahed J, Barkay H, Anderson KE, et al. (2021) Effect of Deutetrabenazine on Metabolic Parameters in the Treatment of Tardive Dyskinesia. Cns Spectrums. 26: 159-160
Salles PA, Mata IF, Fernandez HH. (2021) Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of view. Parkinsonism & Related Disorders. 88: 51-57
Liao JY, Salles PA, Shuaib UA, et al. (2021) Correction to: Genetic updates on paroxysmal dyskinesias. Journal of Neural Transmission (Vienna, Austria : 1996)
Isaacson SH, Ballard CG, Kreitzman DL, et al. (2021) Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients. Parkinsonism & Related Disorders. 87: 25-31
Liao JY, Salles PA, Shuaib UA, et al. (2021) Genetic updates on paroxysmal dyskinesias. Journal of Neural Transmission (Vienna, Austria : 1996)
Wilhelm A, Anderson KE, Fernandez HH, et al. (2021) Comparison of Safety and Tolerability of Deutetrabenazine During Titration and Maintenance in Patients with Tardive Dyskinesia. Cns Spectrums. 26: 164-180
See more...